GlobeNewswire Inc.··NaCocrystal Pharma to Present Phase 1 Data for Oral Norovirus Treatment at ICAR 2026
Cocrystal Pharma will present Phase 1 data for oral norovirus treatment CDI-988 at 2026 conference, marking progress for first oral antiviral targeting this virus.
COCPnorovirusprotease inhibitor